首页> 外文期刊>European review for medical and pharmacological sciences. >The clinical study on the treatment for acute cerebral infarction by intra-arterial thrombolysis combined with mild hypothermia
【24h】

The clinical study on the treatment for acute cerebral infarction by intra-arterial thrombolysis combined with mild hypothermia

机译:动脉内溶栓联合亚低温治疗急性脑梗死的临床研究

获取原文
           

摘要

OBJECTIVE: This study was purposed to evaluate the clinical efficacy of the treatment for acute cerebral infarction by intra-arterial thrombolysis combined with mild hypothermia. PATIENTS AND METHODS: Thirty patients, diagnosed with acute anterior circulation cerebral infarction and admitted to the Hospital between January 2013 and September 2015, were randomly divided into the control group and the mild hypothermia group, each group comprising 15 cases. The treatment of intra-arterial thrombolysis combined with mild hypothermia was administered to the mild hypothermia group, while only the treatment of intra-arterial thrombolysis was performed on the control group. The National Institutes of Health Stroke Scale (NIHSS) score, Modified RANKIN Scale (MRS) score, cerebral hemorrhage transformation, pulmonary infection, and the incidence of gastrointestinal bleeding of the two groups were compared on day 14, 30, and 90 following the onset of the disease. RESULTS: The prognosis (MRS score) of the group with mild hypothermia combined with intra-arterial thrombolysis was lower than that of the group treated only with intra-arterial thrombolysis (p < 0.05). The incidence of cerebral hemorrhage transformation of the group with mild hypothermia combined with intra-arterial thrombolysis was also lower than that of the control group (p < 0.05). There was no significant difference in the incidence of pulmonary infection and gastrointestinal bleeding between the two groups. CONCLUSIONS: Treatment of patients suffering from acute cerebral infarction by means of intra-arterial thrombolysis in combination with mild hypothermia can result in reduced risk of hemorrhagic transformation and improve clinical outcome.
机译:目的:本研究旨在评估动脉内溶栓联合轻度低温治疗急性脑梗死的临床疗效。患者与方法:2013年1月至2015年9月期间被诊断为急性前循环脑梗死并入院的30例患者随机分为对照组和亚低温治疗组,每组15例。亚低温治疗组采用动脉内溶栓联合轻度低温治疗,而对照组仅进行动脉内溶栓治疗。美国国立卫生研究院卒中量表(NIHSS)评分,改良的RANKIN量表(MRS)评分,脑出血转变,肺部感染和胃肠道出血发生率在发病后第14、30和90天进行了比较这种疾病。结果:亚低温合并动脉内溶栓治疗组的预后(MRS评分)低于单纯动脉内溶栓治疗组(p <0.05)。亚低温合并动脉内溶栓治疗组脑出血转化的发生率也低于对照组(p <0.05)。两组之间肺部感染和胃肠道出血的发生率无显着差异。结论:通过动脉内溶栓结合轻度低温治疗急性脑梗死患者可以降低出血性转化的风险并改善临床疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号